Overview

Royalty Pharma plc is engaged in investing in late stage biopharmaceutical products. The Company invests in academic institutions, research hospitals and not-for-profits through small and...

Open

$0.00

Prior close

$58.93

Today's high

$0.00

Today's low

$0.00

52 Week high

$64.38

52 Week low

$34.63

News

GlobeNewsWire • 3 days ago • RPRX

Royalty Pharma announces $7.5 million gift to Blood Cancer United to expand Therapy Acceleration Program

Seeking Alpha • 4 days ago • RPRX

Royalty Pharma plc (RPRX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

GlobeNewsWire • 9 days ago • RPRX

Royalty Pharma to present at upcoming investor conferences

Benzinga • 10 days ago • RPRX

Novartis Stock Drops as Trial Failures Ripple Across Biotech Partners

GlobeNewsWire • 14 days ago • RPRX

Royalty Pharma announces update on Novartis' Phase 3 topline results for pelacarsen